DEFYMED October 27, 2016 – New York. Defymed is the winner at the Medstartup- Galien Awards 2016 – Category ” Best Innovative trial design leading to quicker and better therapeutic outcome”.  In this contest, Defymed collaborates with Semma Therapeutics to obtain a preclinical validation of stem cell derived insulin secreting cells in the bioartificial pancreas MailPan®. For more info